21101-79-1 Usage
Description
2-(Ethylthio)benzoic acid, also known as 2-ethylthiobenzoic acid, is an organic compound with the chemical formula C9H10O2S. It is a derivative of benzoic acid, with the addition of an ethylthio group (-C2H5S) in the ortho position. 2-(ETHYLTHIO)BENZOIC ACID is characterized by its potential anti-inflammatory and analgesic properties, as well as its use as a building block in the synthesis of various pharmaceuticals and agrochemicals. The ethylthio group adds some bulk and steric hindrance, which may impact the compound's reactivity and biological activity.
Uses
Used in Pharmaceutical Research:
2-(Ethylthio)benzoic acid is used as a building block in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure and properties make it a valuable component in the development of new drugs and chemical compounds.
Used in Organic Synthesis:
2-(Ethylthio)benzoic acid is used as a key intermediate in organic synthesis, allowing for the creation of a wide range of chemical products. Its versatility and reactivity make it an essential component in the synthesis of various organic compounds.
Used in Anti-inflammatory Applications:
2-(Ethylthio)benzoic acid has been studied for its potential anti-inflammatory properties, making it a candidate for use in the development of anti-inflammatory medications and treatments.
Used in Analgesic Applications:
Due to its potential analgesic properties, 2-(ethylthio)benzoic acid may be utilized in the development of pain-relief medications and therapies, providing an alternative to existing analgesics.
Check Digit Verification of cas no
The CAS Registry Mumber 21101-79-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,1,0 and 1 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 21101-79:
(7*2)+(6*1)+(5*1)+(4*0)+(3*1)+(2*7)+(1*9)=51
51 % 10 = 1
So 21101-79-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O2S/c1-2-12-8-6-4-3-5-7(8)9(10)11/h3-6H,2H2,1H3,(H,10,11)
21101-79-1Relevant articles and documents
-
Irving,Fernelius
, p. 1427 (1956)
-
DNA binding and antitumor activities of platinum(IV) and zinc(II) complexes with some S-alkyl derivatives of thiosalicylic acid
Besser Silconi, Zana,Benazic, Sasa,Milovanovic, Jelena,Jurisevic, Milena,Djordjevic, Dragana,Nikolic, Milos,Mijajlovic, Marina,Ratkovic, Zoran,Radi?, Gordana,Radisavljevic, Snezana,Petrovic, Biljana,Radosavljevic, Gordana,Milovanovic, Marija,Arsenijevic, Nebojsa
, p. 719 - 729 (2018/07/31)
A series of complexes of platinum(IV) (C1–C5) and zinc(II) (C6–C10) with S-alkyl derivatives of thiosalicylic acid were prepared and characterized. The interactions of the complexes with calf thymus DNA were analyzed by absorption (UV–Vis) and emission spectral studies (ethidium bromide displacement studies). The cytotoxic activities of complexes C1–C10 were determined against mouse B cell lymphocytic leukemia cells (BCL1), human B-prolymphocytic leukemia (JVM-13), mouse mammary carcinoma cells (4T1), and human mammary carcinoma cells (MDA-MB-468) and compared to the activities of the free ligand precursors and cisplatin. The cytotoxicities of the platinum(IV) and zinc(II) complexes toward mouse tumor cell lines were higher compared with their effects on human tumor cell lines. The zinc(II) complex C9 showed the highest antitumor activity toward the tested human cell lines, while the platinum(IV) complex C4 exhibited the highest antitumor activity toward mouse BCL1 and 4T1 cells. Both C4 and C9 have ligands derived from S-propyl thiosalicylic acid.
New piperazine derivatives having anti-cancer effect, combination therapeutic effect with radiation, and anti-diabetic effect, and PPAR activity, and medical use thereof
-
Paragraph 0068; 0069; 0075; 0076, (2018/10/03)
The present invention relates to a novel piperazine derivative having an anti-cancer effect, a combination therapeutic effect with radiation, and an anti-diabetic effect, and to a medical use thereof. The piperazine derivatives are PPAR-γ ligand, and have
